Earnings Feed
Sign Up
Home/Filings/4/0001127602-21-001603
4//SEC Filing

Bisaccia Lisa 4

Accession 0001127602-21-001603

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 5:08 PM ET

Size

20.0 KB

Accession

0001127602-21-001603

Insider Transaction Report

Form 4
Period: 2021-01-12
CVS HEALTH CorpCVS
Bisaccia Lisa
SVP, Chief HR Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-01-12$74.29/sh+25,177$1,870,399→ 71,765 total
  • Sale

    Common Stock

    2021-01-12$77.00/sh−25,177$1,938,629→ 46,588 total
  • Exercise/Conversion

    Stock Option

    2021-01-12−25,177→ 0 total
    Exercise: $74.29From: 2015-04-01Exp: 2021-04-01→ Common Stock (25,177 underlying)
Holdings

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (141,405 underlying)
    141,405

  • ESOP Common Stock

    (indirect: Direct)
    634

  • Stock Unit

    32,020.232

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (55,098 underlying)
    55,098

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (64,222 underlying)
    64,222

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (468.924 underlying)
    468.924

  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (34,241 underlying)
    34,241

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (98,558 underlying)
    98,558

  • Common Stock (restricted)

    6,147

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (39,433 underlying)
    39,433
Footnotes (11)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F10]The number of shares subject to the option were calculated using a 30-day average price.
  • [F11]Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
  • [F2]Option became exercisable in four equal annual installments, commencing 4/1/2015.
  • [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F4]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F9]Option became exercisable in four equal annual installments, commencing 4/1/2020.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001479663

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:08 PM ET
Size
20.0 KB
View on SEC.gov